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Abstract
Glucocorticosteroids are the first line therapy for moderate-severe flare-ups of ulcerative
colitis. Despite that, up to 60% of patients do not respond adequately to steroid treatment.
Previously, we reported that low IL-10 mRNA levels in intestine are associated with a poor
response to glucocorticoids in active Crohn’s disease. Here, we test whether IL-10 can
favour the response to glucocorticoids by improving the TNFα-induced intestinal barrier
damage (assessed by transepithelial electrical resistance) in Caco-2 monolayers, and their
possible implications on glucocorticoid responsiveness in active ulcerative colitis. We show
that the association of IL-10 and glucocorticoids improves the integrity of TNFα-treated
Caco-2 cells and that p38 MAPK plays a key role. In vitro, IL-10 facilitates the nuclear trans-
location of p38 MAPK-phosphorylated thereby modulating glucocorticoids-receptor-α, IL-
10-receptor-α and desmoglein-2 expression. In glucocorticoids-refractory patients, p38
MAPK phosphorylation and membrane desmoglein-2 expression are reduced in colonic
epithelial cells. These results suggest that p38 MAPK-mediated synergism between IL-10
and glucocorticoids improves desmosome straightness contributing to the recovery of intes-
tinal epithelium and reducing luminal antigens contact with lamina propria in ulcerative coli-
tis. This study highlights the link between the intestinal epithelium in glucocorticoids-
response in ulcerative colitis.
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Introduction
Ulcerative colitis (UC) and Crohn’s disease (CD), collectively known as Inflammatory Bowel
Disease (IBD), are chronic inflammatory illnesses mainly occurring in Western societies, but
with increasing incidence in developing countries. As they are chronic diseases with no defini-
tive cure, they have a great impact on patients’ quality of life and account for a great consump-
tion of health resources.
Glucocorticoids (GC) are very often used for the treatment of active CD and still remain the
first line therapy for moderate-severe attacks of UC [1]. In spite of that, up to 60% of patients
do not adequately respond to steroid treatment [2]. Lack of response does not diminish the
side effects of GC and implies the use of more aggressive and expensive rescue therapies.
Previous studies have suggested that defects in intestinal lamina propria T cell apoptosis are
related to the pathogenesis of CD [3]. Studies by our group have shown that CD patients who
did not respond to GC have a decreased intestinal T and B cell apoptosis, as compared to GC
responders [4]. However, other mechanisms could also account for steroid resistance in IBD.
Steroid treatment failure has been related to the some polymorphisms in the multidrug resis-
tance-1 (MDR-1) gene [5], resulting in increased amounts of the drug detoxifying P-glycopro-
tein 170 (Pgp-170), which decreases the intracellular levels of GC [5]. Other studies have
focused on the GC receptor (GCR) -α function, either because of impaired expression or by
blockade by GCR -β [6–8].
Although most immunosuppressive actions of GC have been reported on immune cells
[9,10], there are evidences proving that they also act on the intestinal epithelial cells. Enhanced
epithelial uptake of glucose following oral administration of dexamethasone does not occur
in GCRα-deficient mice, demonstrating the involvement of epithelial cells in GC-induced
actions [11].
Recently, our group has reported that low IL-10 mRNA levels in intestinal baseline biopsies
are associated with a poor response to GC in active CD [4]. Furthermore, deficiency of this
immune regulatory cytokine in animal models is associated with increased intestinal perme-
ability and development of spontaneous colitis [12]. In intestinal epithelial cells, IL-10 is able of
reducing TNFα-induced endoplasmic reticulum stress [13]. Also, other members of the IL-10
family, such as IL-22, also have beneficial effects on intestinal epithelial cells through the acti-
vation of STAT-3 [14].
As a whole, all these data suggest that part of the anti-inflammatory effects of IL-10 could be
accounted for their actions on the intestinal epithelium, by regulating the barrier function.
However, the molecular mechanisms of these actions, and how they affect GC response, are
not well understood. Therefore, in the present study we wanted to test whether the presence of
IL-10 can favour the response to GC by improving the TNF-α-induced intestinal barrier dam-
age in confluent Caco-2 cell monolayers. In addition, the possible implications of some of the
in vitro findings on GC responsiveness in UC were investigated in a series of biopsy samples
from GC sensitive and refractory UC patients.
Methods
Materials
Dulbecco's modified Eagle's medium, fetal bovine serum, nonessential aminoacids, penicillin,
streptomycin, rhTNFα, rhIL-10, LDS Sample Buffer (4x), 10x reducing agent, 4–12%
SDS-PAGE gels, Alexa Fluor 555 Goat anti-mouse, Alexa Fluor 488 Donkey anti-mouse,
Hoechst 33342, and TaqMan Assays (Life Technologies, Paisley, UK); p38 MAP Kinase
inhibitor (SB203580) (InvivoGen, San Diego, CA, USA); Tris-HCl, NaCl, NP-40 detergent,
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deoxycholic acid sodium salt (DOC), sodium dodecyl sulfate (SDS), Na3VO4, Dimetil Sulfóx-
ido (DMSO), phenylmethyldulfonyl fluoride, NaF, Protease Inhibitor Cocktail (P8340), Tri-
chloroacetic acid, Tris-base, glycine, methanol, DPX mounting media, paraformaldehyde,
sucrose, Bovine Serum Albumin (BSA), glutaraldehyde, NaOH, Sodium cacodylate, HCl,
osmium tetroxide, toluidine blue, uranil acetate, lead citrate and Mouse Anti-α-tubulin
(clone B5-1-2) (Sigma-Aldrich, St. Louis, MO, USA); Blocking buffer Odyssey, Donkey anti-
mouse IRDye800CW and Donkey anti-rabbit IRDye680 (LI-COR, Lincoln, NE, USA);
Mouse Anti-phospho-p38 MAPK (Thr180/Tyr182) (28B10), Rabbit Anti-p38 MAPK (Cell
Signaling Technology, Beverly, MA, USA); Mouse Anti- Desmoglein (DSG)-2 (Acris anti-
bodies, Herford, Germany); miRNeasy Mini Kit (Qiagen, Gaithersburg,MD, USA); Prime-
Script RT reagent (Perfect Real Time) kit (TAKARA, Otsu, Japan); fluoroprep mounting
media (Biomerieux, Marcy d’Etoile, France); tEpon 812 embedding kit (Tousimis, Rockville,
MD, USA); Methyl-prednisolone (as a GC) (Urbason, Sanofi, Paris, France). Caco-2 cell line
(ECACC, UK) was kindly provided by Dr. A. Río (Research Institute of Health Sciences ‘Ger-
mans Trias i Pujol’ of Badalona, Spain).
Epithelial cell culture
The human colon cell line Caco-2 was used for in vitro assays. This cell line was cultured in
Dulbecco's modified Eagle's medium containing 10% fetal bovine serum, 2% nonessential
amino acids, 100 U/ml penicillin, and 100 μg/ml streptomycin and kept in a humidified incu-
bator at 37°C with 5% CO2. Media of Caco-2 cells were changed 2 times per week. Cells were
grown to confluence on 24-well cellulose transwell inserts 0.4 μm pore size, high density (BD
Falcon, Franklin Lakes, NJ, USA) and 21 days after seeding, Caco-2 cells spontaneously differ-
entiate into a highly functionalized epithelial barrier exhibiting similar structural and biochem-
ical characteristics as mature enterocytes [15][16][17]. Then TNF-α (100 ng/mL), GC (50 μM),
IL-10 (20 ng/ml) and/or SB203580 (20 μM in DMSO) were added to the basal medium,
depending on the experimental conditions, during 48h with one medium change at 24h.
SB203580 inhibits only the activity but not the phosphorylation of p38 MAPK, by binding to
its catalytic residues (ATP binding domain) [18]. The resulting groups were: TNF, TNF_GC,
TNF_IL10, TNF_GC_IL10, TNF_GC_IL10_SB203580, and a control group (medium alone)
was also included. Each experimental condition was replicated five times.
Intestinal biopsies collection
The colonic samples used in this study were collected from a single-center, prospective, obser-
vational study on Cytomegalovirus (CMV) infection in UC patients [19]. Demographic and
clinical data were recorded. CMV-free UC patients were divided into two groups according to
their response to GC: a) GC-responsive group (n = 8 subjects) consisted of active UC patients
admitted for the treatment of an acute flare requiring iv steroid treatment (1 mg/kg/day of
prednisolone or equivalent); b) GC non-responsive group (n = 7 subjects) consisted of active
UC patients refractory to steroid treatment. GC-refractoriness was defined as the absence of
clinical improvement after a course of 7 to 10 days of 1 mg/kg/day of iv prednisolone, in which
case iv Cyclosporine A (4 mg/kg/day) was started.
Patients were included immediately prior to or during the first 24 hours after starting ste-
roids or Cyclosporine A. Patients with UC limited to the rectum, those with previous episodes
of colonic CMV disease, neoplasia, immunodeficiency diseases, and systemic steroid treatment
30 days before the inclusion were excluded from the study.
Rectal biopsies were obtained by colonoscopy or flexible sigmoidoscopy with gentle insuffla-
tion and immediately routinely processed for paraffin embedding. These samples were stored
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properly in the Germans Trias i Pujol BioBank (Badalona, Spain) to guarantee their conser-
vation. In active UC patients, tissue samples were taken from the centre of the largest muco-
sal ulcers, when possible. The sample collection in UC groups was performed at the same
time of patient inclusion (pre-treatment) and also after 7–10 days of steroid treatment (post-
treatment).
The study protocol was previously approved by the ‘Germans Trias i Pujol' hospital Ethics
Committee (06/03/1999, Badalona). Patients were included after obtaining their written
informed consent.
Assessment of Intestinal Epithelial Barrier Function
Transepithelial electrical resistance (TEER) was used as a measure of paracellular permeability
and barrier function in confluent Caco-2 cell monolayers. To evaluate the stimulus effect on
the epithelial barrier, TEER was measured at baseline and after 48-h of stimulation, by means
of a Millicell-ERS epithelial volt-ohm meter (Millipore, Billerica, MA, USA). The blank mea-
surements (transwell without cell monolayer) were subtracted from TEER values of each exper-
imental condition and also were adjusted for the filter surface (0.3 cm2), and the values were
expressed as ohms (O) per cm2. The results represent the percentage of final TEER increases
respect of their basal TEER value.
Western blot analyses
Western blot of 48h-incubation extract from homogenized Caco-2 cell monolayers was per-
formed in a RIPA buffer (25 mM Tris-HCl at pH 8.0, 150 mMNaCl, 1% NP-40, 1% DOC,
0,1% SDS, 1 mMNa3VO4, 1 mM phenylmethyldulfonyl fluoride, 1 mMNaF and 10 ul/ml pro-
tease inhibitor cocktail). The cellular extracts were incubated during 45 minutes with gentle
shaking and centrifuged at 16,000 g for 15 minutes. The supernatants obtained were precipi-
tated by 100% Trichloroacetic acid-2% DOCmethod and denaturized in 1x LDS sample buffer
and 1x reducing agent at 70°C for 10 minutes. Subsequently, the samples were separated on
4–12% SDS-PAGE gels at 200 V, and electrotransferred at 100 V for 90 minutes onto nitrocel-
lulose membranes in 27 mM Tris-base, 197 mM glycine and 20% methanol (pH 8.2) buffer.
After, the membranes were blocked and were incubated overnight at 4°C with specific antibod-
ies (Anti-phospho-p38 MAPK 1:250 (v/v); Anti-p38 MAPK (total p38 MAPK) 1:250 (v/v);
Anti-α-tubulin 1:6000). Donkey anti-mouse IRDye800CW and Donkey anti-rabbit IRDye680
(1:20000 (v/v)) were used to detect primary antibodies. Fluorescent signal were captured by
Odyssey scan (LI-COR, Lincoln, NE, USA) and each protein was quantified by Odyssey Infra-
red Imaging software (v3.0) and normalized to α-tubulin. The results are expressed as a ratio to
the control group to normalize the band intensity between nitrocellulose membranes.
Real-time PCR
Total RNA was isolated from Caco-2 cells homogenized with trizol using the RNeasy Mini Kit
according to the manufacturer’s instructions. The RNA integrity was evaluated by Experion
system (BioRad, Hercules, CA, USA) and only were used those samples with a RNA Quality
Index 7. cDNA was generated using PrimeScript RT reagent (Perfect Real Time kit). In brief,
800ng of total RNA were mixed with oligo dT primer, PrimeScript RT Enzyme and Random 6
Mers, and the retrotranscription was carried out into a thermocycler (NyxTechnik ATC401;
San Diego, CA, USA).
Real-time PCR was performed using TaqMan Assays (IL-10Rα_Hs00155485-m1; IL-
10Rβ_Hs00175123-m1; GCRα_Hs00353740; DSG2_Hs00170071-m1; DSC2_Hs00951428-m1;
E-Cadherin_Hs01023894-m1) and the results were normalized with GAPDH as housekeeping
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(GAPDH_Hs02758991-g1). The PCR thermal cycling was as follows: initial denaturing at 95°C
/ 10 seconds, 40 cycles of 95°C / 15 seconds, and 60°C / 1 minute. Thermal cycling was per-
formed using a LightCycler 480 system (Roche Diagnostics, Basel, Switzerland). Folds changes
respect to control group were calculated by 2-ΔΔCt.
Immunohistochemistry
Paraffin embedded biopsy samples from UC patients were used to evaluate the phospho-p38
MAPK. Four μm histological sections were deparaffinised and rehydrated in xylene/ethanol
solutions. Antigen retrieval was done by boiling in citrate buffer (pH 6) for 45 minutes and the
endogen peroxidase was inhibited by hydrogen peroxide (3%) for 10 minutes. The primary
antibody anti-phospho-p38 MAPK at 1:50 (v/v) was revealed with Ultraview Universal DAB
kit, and counterstained with Harris's haematoxylin. Immunostaining was carried out in an
automatic BenchMark XT station (Ventana Medical Systems, Oro Valley, AZ, USA). Slides
were then dehydrated and mounted in DPX mounting media. Negative controls were obtained
by omitting primary antibody and a mammary gland tissue was used as a positive control to
test the antibody specificity. Between 10–20 slides fields were examined by a pathologist blind
to the samples codes using a Axioskop 2 light microscope (Carl Zeiss S.A., Oberkochen, Ger-
many) and DFC480 digital camera (Leica Microsystem, Cambridge, UK) to capture images.
The relative quantification of positive nuclei (p38 MAPK+) was made with the following score:
0- No positive nuclear staining; 1- few labelled nuclei; 2-many labelled nuclei; 3- all or almost
all labelled nuclei.
Immunofluorescence evaluations
Caco-2 cells were fixed with fresh ice-cold 4% paraformaldehyde / 2% sucrose for 40 minutes
at 4°C and following permeabilized with methanol at -20°C to localized intracellular phospho-
p38 MAPK. After, the cells were blocked with 3% BSA 30 minutes at room temperature, and
incubated overnight at 4°C with primary antibody (anti-phospho-p38 MAPK 1:100 (v/v) in 1%
BSA / PBS buffer), or without antibody as negative control (data not shown). Alexa fluor 555
Goat anti-mouse was used as secondary antibody (1:200 (v/v) in 1%BSA/PBS as buffer) and
Hoechst stain (0.4 μg/ml) was added for nucleus counterstain. Samples were mounted with
fluoroprep mounting media and assessed within the next 24 hours using a fluorescence micro-
scope with apotome module (Zeiss AxioObserver Z1) and AxioCamMRc 5 camera. At least 10
individual fields were captured randomly and analyzed with AxioVision software (v 4.8.1). The
results were expressed as percentage of cells with nuclear or/and cytoplasmic staining.
DGS2 intracellular localization from paraffin-included intestinal biopsies of UC patients
was assessed. Sample preparation and antigen retrieval for fluorescent staining were the same
as immunochemistry protocol. Anti-DSG-2 (1/50 (v/v) 1% BSA / PBS as buffer) was added as
primary antibodies. The slides were incubated 1 hour at room temperature with Alexa Fluor
488 Donkey anti-mouse (1:100 in 1%BSA/PBS as buffer) secondary antibody. Right now, the
protocol was the same as the Caco-2 cells. Results were quantified using a score from 0 to 3
depending on the paracellular staining intensity.
Transmission electron microscopy
Paracellular gaps were detected by transmission electron microscopy. In short, Caco-2 cell
monolayers were fixed with Karnovsky buffer (pH 7.4) for 5 hours. After that, the cells were
washed with cocodilate buffer (0.1 M, pH 7.4), and fixed with 1% osmium tetraoxide for 1h.
Then the samples were dehydrated in graded alcohols, and embedded in a mixture of propyl-
ene oxide and Epon 812 resin at different concentration. Semi-thin 0.5 μm-sections were
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stained by toluidine blue to select the region of interest, and 0.1 μm ultra-thin sections were
stained with 5% uranil acetate/citrate. The ultra-thin sections were examined and photo-
graphed using a JeoL-1011 electronic microscope (Jeol Ltd., Tokyo, Japan). The results
expressed the number and intercellular gaps localization in each experimental condition.
Statistical Analysis
Data are expressed as median with IQR or as means ± SEM. TEER, western blot, real-time
PCR, immunohistochemistry and immunofluorescent results were analysed using Mann-
Whitney test. The changes during the treatment course in UC patients were evaluated with
Wilcoxon test. To paracellular gap evaluations by transmission electron microscopy used Chi-
Square test (X2). All statistical analyses were performed and all graphs were generated with
SPSS.15 (SPSS Inc.). Values of p0.05 were considered to be statistically significant.
Results
The association of IL-10 and GC improves the integrity of TNF-treated
intestinal epithelial cells in vitro
To assess the effect of GC and IL-10 on the epithelial layer, we conducted experiments on
Caco-2 cell monolayers by measuring the TEER as a surrogate of the integrity of the confluent
cell monolayer, as well as the strength of paracellular junctions. Measures were made before
and after addition of GC, IL-10 or both, either in the presence or absence of TNF-α in the cul-
ture medium.
In the absence of TNF-α, no differences in TEER value among groups were found (median
(IQR): control -5.9 (-10.5, 4.5); GC -4.39 (-25.2, 3.71); IL10–6.8 (-13.2, 8.5); GC_IL10 7.9
(-20.7,14.1)). However, a significant decrease of TEER was observed in the presence of TNF-α
as compared to control conditions (Fig 1). Such a decrease was not reversed either by GC or
IL-10 alone, but returned to control values when both agents were simultaneously added to the
medium (Fig 1).
p38 MAPK plays a key role in the synergistic actions of IL-10 and GC on
the epithelium
In order to explore the mechanisms of the above-mentioned effect of IL-10 and GC, several
proteins of both intracellular signalling pathways and tight junctions (TJ) were measured by
Western blot in cell lysates of the same above groups. No changes were found in the TJ proteins
(zonula occludens (ZO)-1 and occludin), among groups (data not shown). The total amount of
p38 MAPK were similar to control condition in all TNF-treated groups (Fig 2A). On the other
hand, the presence of IL-10 –alone or associated to GC—resulted in intermediate levels of
phospho-p38 MAPK (Fig 2B). To ascertain the role of p38 MAPK in the action of GC and IL-
10 on TEER, a second series of experiments was carried out comparing TEER among controls,
TNF_GC, TNF_GC_IL-10, and a fourth group with TNF, GC, IL-10 and an inhibitor of p38
MAPK activity (SB203580) (Fig 3). As in the previous experiment, the association of GC and
IL-10 reversed the reduction of TEER to control values, but this effect did not occur in the pres-
ence of the inhibitor of p38 MAPK activity (Fig 3).
IL-10 facilitates the nuclear translocation of phosphorylated p38 MAPK
in the presence of TNF-α and GC
Immunofluorescence staining of Caco-2 cell monolayers allowed to verify that the presence of
IL-10 in the culture medium, together with TNF-α and GC, facilitated nuclear translocation of
Epithelium Influences on Steroid Response
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phospho-p38 MAPK, an effect that was reversed by adding the p38 MAPK SB203580 inhibitor
(Fig 4).
IL-10-induced p38 MAPK activation modulates the expression of GCR-
α, IL-10 R-α and DSG-2 in Caco-2 cell monolayers
With the aim to investigate the consequences of IL-10-induced p38 MAPK activation, we stud-
ied the expression of potentially implicated genes in the same in vitro experimental groups of
confluent monolayers of Caco-2 cells. First, we measured the expression of GCR -α and -β, IL-
10R-α and -β, as well as IL-10 itself. Also, the expression of E-cadherin, DSG-2, and Desmoco-
lin-2 (DSC-2), as proteins involved in adherens junctions (AJ) and desmosomes, were evalu-
ated (since we had failed to disclose any change in TJ-related proteins). Expression of IL-10
and GCR-β was absent in all experimental conditions, while expression of IL-10R-β—although
present—showed no differences among groups (Fig 5A). However, GCR-α and IL-10R-α
expression were significantly higher in the presence of IL-10 together with TNF-α and GC, as
Fig 1. IL-10 and GC restore control TEER values in Caco-2 cell monolayers. Figure represents median values (IQR, limits) of percent TEER changes in
Caco-2 cell monolayers after 48h of incubation with different stimuli. *p 0.02 vs control and TNF_GC_IL10.
doi:10.1371/journal.pone.0130921.g001
Epithelium Influences on Steroid Response
PLOS ONE | DOI:10.1371/journal.pone.0130921 June 19, 2015 7 / 16
compared to the cell monolayers treated only with TNF-α and GC (Fig 5B and 5C). The
addition of the p38 MAPK inhibitor SB203580 resulted in a significant reduction of the IL-
10-induced expression of GCR-α (Fig 5A), while the expression of IL-10R-α showed a non-
significant trend to increase (Fig 5B).
The expression of E-cadherin and DSG-2 significantly increased in the presence of IL-10,
TNF-α and GC, with respect to monolayers with TNF-α and GC alone (Fig 6A and 6B). The
addition of the inhibitor of p38 MAPK activity significantly reduced the expression of DSG-2
(Fig 6B), while it had no impact on that of E-cadherin (Fig 6A).
In order to ascertain if the results on the expression of paracellular junction-related mole-
cules have a morphological correlation, we examined monolayers of confluent cells in the pre-
vious experimental conditions by transmission electron microscopy. We found that the TJ
remained closed in all experimental conditions. However, the AJ and desmosomes (zones rich
in cadherins) were usually open in TNF_GC group (57%), closed in the TNF_GC_IL-10 group
(40%), and open again when the p38 MAPK activity was inhibited (60%) (Fig 7), but these dif-
ferences were not statistically significant.
Implications of the in vitro findings on GC responsiveness in UC
p38 MAPK phosphorylation is reduced in colonic epithelial cells from GC-refractory
UC patients. To understand the relationship of p38 MAPK with the response to GC in active
UC, immunostaining of phosphorylated p38 MAPK was done in colonic biopsy samples from
steroid-responsive (n = 8) and non-responsive (n = 7) UC patients, obtained before and after
treatment with GC. Immunostaining for phosphorylated p38 MAPK in epithelial cells was
Fig 2. IL-10 reverts the GC-mediated decrease in phosphorylated-p38 MAPK activity. Figure shows
(median (IQR, limits)) the ratio for total p38 MAPK (Panel A) and phosphorylated p38 MAPK (Panel B) versus
control group in TNF-treated Caco-2 cell monolayers. An example of Western blot bands obtained for these
proteins and α-tubulin (as housekeeping protein) is provided in Panel C. *p 0.026 vs. all other groups,
#p = 0.028 vs. TNF_IL10 and TNF_GC_IL10;.
doi:10.1371/journal.pone.0130921.g002
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predominantly nuclear. Despite the small number of patients, the number of positive nuclei in
baseline biopsies was clearly decreased in GC-refractory patients (Fig 8A and 8B).
Changes of DSG-2 expression in the membrane of intestinal epithelial cells of patients
with active UC. Immunofluorescence for DSG-2 showed a greater intensity of staining in GC
Fig 3. SB203580 reverses the synergistic action of IL-10 and GC on TEER in Caco-2 cell monolayers.
Values are median (IQR, limits) of percent TEER changes in Caco-2 cell monolayers after 48h of incubation
with different stimuli. *p 0.042 vs control.
doi:10.1371/journal.pone.0130921.g003
Fig 4. Both IL-10 and GC facilitate the phosphorylated-p38 MAPK nuclear translocation in Caco-2 cell monolayers. Panel A shows the nuclear
arrangement of phosphorylated p38 MAPK in cultured Caco-2 cell monolayers, by immunofluorescence staining with anti-phospho-p38 MAPK (Thr180/
Tyr182) (red) and Hoechst dye (blue). Scale bar 20 μm.White squares show images without Hoechst staining. Panel B shows the median (IQR, limits)
percentage of cells with positive phospho-p38 MAPK nuclear staining. *p 0.021 vs. other groups, #p 0.043 vs. TNF_GC_IL-10_SB203580.
doi:10.1371/journal.pone.0130921.g004
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sensitive than in refractory patients, both before and after treatment (Fig 9). In addition, DSG-
2 expression decreased with treatment only in GC refractory patients (Fig 9).
Discussion
In this study, confluent Caco-2 cell cultures treated with TNF-α were used to investigate the
effects of GC and IL-10 on the epithelial barrier function in inflammatory conditions. Caco-2
cell line undergoes in culture a process of spontaneous differentiation that leads to the forma-
tion of a monolayer of cells, expressing several morphological and functional characteristics of
mature enterocyte, including functional paracellular junctions and well developed and orga-
nized microvilli on apical membrane [20]. These features makes it a good model of intestinal
barrier.
The primary result of these experiments showed that the association of GC and IL-10 is able
to revert the TNF-induced decrease of TEER (as a measure of epithelial integrity), an effect
that does not occur when both agents are used separately (Fig 1). Such a synergistic action had
not been previously described, despite that IL-10 therapy has been reported to improve intesti-
nal epithelial function in a model of total parenteral nutrition [21], and GC alone prevent
Fig 5. IL-10 plus GC increases GCR-α (p38 MAPK-dependent) and IL-10R-α expression in Caco-2 cell monolayers.Graphs represent fold change
values (2-AACt) of IL-10R- β (Panel A), GCR-α (Panel B) and IL-10R-α (Panel C) expression, with respect to their basal condition (control or DMSO group).
*p 0.04 vs other groups.
doi:10.1371/journal.pone.0130921.g005
Fig 6. IL-10 plus GC increases DSG-2 expression dependent on p38 MAPK activity in Caco-2 cells.Graphs represent the fold change values (2-AACt) of
E-cadherin (Panel A), DSG-2 (Panel B) and DSC-2 (Panel C) expression, with respect to their basal condition (control or DMSO group). *p 0.05 vs other
groups.
doi:10.1371/journal.pone.0130921.g006
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TNF-induced barrier disruption in vitro [22]. This result, together with our previous finding
that steroid responsiveness is associated with the presence of IL-10 mRNA in the colon [3],
argue for a necessary role of IL-10 on GC therapeutic effect on intestinal inflammation.
This role of IL-10 on epithelial barrier straightness in presence of GC appears to be associ-
ated to its ability to maintain some degree of p38 MAPK activation. In fact, IL-10 was able of
maintaining some levels of activated p38 MAPK (Fig 2B), but TEER increased only when this
cytokine was combined with GC, an effect that was abolished in the presence of an inhibitor of
p38 MAPK activity (Fig 3). These findings suggest that some level p38 MAPK activation is nec-
essary (but not sufficient) condition to maintain the integrity of the intestinal epithelial barrier.
In this sense, IL-10 maintains a degree of phosphorylated-p38 MAPK that could favours the
GC paracellular function.
Activated p38 MAPK has been traditionally associated to increased inflammatory activity in
the gut of IBD patients [23,24]. However, experimental and clinical studies have shown con-
flicting results with respect to the role of p38 MAPK in the intestine. Clinical trials in active CD
treated with inhibitors of p38 MAPK activity yield opposite results depending on the agent
Fig 7. IL-10 and GC preserve p38 MAPK-dependent desmosome integrity and strength in Caco-2 monolayers. Representative transmission electron
microscopy images of the paracellular junctions in Caco-2 cell monolayers treated with GC (Panel A), GC plus IL-10 (Panel B) or GC, IL-10 and SB203580
(Panel C) D: desmosomes; TJ: tight junctions. Magnification varies from 25,000 x to 100,000 x.
doi:10.1371/journal.pone.0130921.g007
Fig 8. p38 MAPK phosphorylation is reduced in colonic epithelial cells fromGC-refractory UC patients before treatment. Panel A shows the
immunostaining score (mean±SEM) of phosphorylated p38 MAPK in colonic biopsies of steroid-responsive and steroid-refractory active UC patients, before
and after GC treatment. *p = 0.028 vs steroid-sensitive patients before treatment. Panel B provides representative images from steroid-refractory UC
biopsies (score value 0–1), and from steroid-sensitive UC biopsies (score value 2–3). Scale bar: 20 μm.
doi:10.1371/journal.pone.0130921.g008
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used [25,26]. Hollenbach et al. found that inhibition of p38 MAPK was able to drastically
reduce colonic NF-kB activity with a consequent improvement of intestinal lesions in a murine
model [27], whereas in other studies inhibition of p38 MAPK activation worsened the course
of 2,4,6-trinitrobenzenesulfonic (TNBS) acid or dextran sulphate sodium (DSS) induced colitis
[28,29].
These conflicting results could be explained by an opposite role of p38 MAPK in immune
and epithelial cells. In fact, it has been reported that DSS- or TNBS-treated mice with myeloid
cell-specific deletion of p38 MAPK alpha have less inflammation and an improved disease con-
dition compared with wild-type mice, whereas mice with intestinal epithelial cell-specific dele-
tion of p38 MAPK alpha had increased progression of colitis that resulted from disrupted
intestinal epithelial homeostasis [30].
The protective action of p38 MAPK on the intestinal epithelium probably lies on its regula-
tory roles on apoptosis, and autophagy [31,32]. NOD2-dependent autophagy requires the
activity of MEKK4 and p38 MAPK, independent of NFkB signalling [32]. RhoA/p38 MAPK
axis contributes to mucosal healing through intestinal epithelial cell migration [33]. It has been
shown that p38 MAPK activity mediated by probiotics in inflammatory conditions strengthens
the TJ [34–36]. Moreover, it has been reported that IL-10-mediated p38 signalling inhibits
inflammation-induced endoplasmic reticulum stress response mechanisms by modulating
ATF-6 nuclear recruitment to the grp-78 gene promoter [13].
The IL-10/GC-mediated p38 MAPK effect on the cell-to-cell adhesion of the intestinal epi-
thelial cells seems to depend on its translocation to the nucleus, as we found that the presence
of both IL-10 and GC increased the number of nuclei positive for phosphorylated p38 MAPK
in Caco-2 cells (Fig 4), a phenomenon not observed when the p38 MAPK activity inhibitor
SB203580 was added. Moreover, the nuclear presence of phosphorylated p38 MAPK was also
higher in intestinal pre-treatment biopsies of GC-responsive UC patients as compared to non-
responsive ones (Fig 8). These observations, together with the finding of increased baseline
Fig 9. Steroid-sensitive UC patients show a greater DSG2 staining. Immunofluorescence staining score (mean±SEM) of DSG2 (Panel A) in colonic
biopsies of steroid-sensitive and steroid-refractory UC patients, before and after treatment. Representative DSG2 staining intensity of steroid-sensitive
(Panel B) and steroid-refractory (Panel C) patients are also provided. All images are 630 x. *p 0.004 vs steroid-refractory patients, #p = 0.023 vs after GC
treatment.
doi:10.1371/journal.pone.0130921.g009
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IL-10 expression in the colon of UC patients who responded to GC [37], suggest that IL-10
induced nuclear translocation of active p38 MAPK could be a prerequisite for GC therapeutic
response.
In an attempt to identify the biological action resulting from IL-10/GC-mediated p38
MAPK signalling, we investigated the expression of several possible target genes. Those of TJ
proteins did not prove to be involved. However, the combination of IL-10 and GC was able to
increase the expression of both E-cadherin and DSG-2 (a cadherin-like desmosomic protein)
in vitro, but only the later was dependent on p38 MAPK activity. Since cadherins are the most
abundant proteins in AJ and desmosomes, it is conceivable than TEER regulation via p38
MAPK would occur through these structures. Cadherins play a main role in regulating intesti-
nal permeability by modulating the expression of Claudin-5 and regulating the function of
Akt/FoxO [38].
Indeed, transmission electron microscopy analysis provided morphological confirmation of
the involvement of desmosomes in paracellular epithelial sealing in presence of IL-10 and GC,
an effect that did not occur when Caco-2 cells were treated with SB203580 (Fig 7). Desmo-
somes are key in the regulation of permeability. In fact, several studies demonstrate that block-
ade of DSG-2 or -3 by specific antibodies is capable of disrupting epithelial integrity and its
barrier function [39–41].
GCRα expression ran in parallel to that of DSG-2, increasing in the presence of IL-10/GC,
and returning to baseline when p38 MAPK phosphorylation was inhibited. This was not the
case for IL-10Rα (and some proteins of its signalling pathway, such as SOCS-3 and IkBα, S1
Fig) which showed a further increase in their expression in the presence of SB203580.
Despite that the addition of IL-10 increases the expression of both GCRα and IL-10Rα in
cellular monolayers, colonic UC biopsies showed lower amounts of both receptors in steroid-
sensitive than in steroid-refractory patients. These apparently contradictory findings could be
interpreted as an unsuccessful attempt of refractory patients to compensate for the lack of IL-
10 (and hence impaired GC action) [37] by increasing the expression of both receptors.
In conclusion, this study demonstrates that the presence of IL-10 enhances the epithelial
barrier via a mechanism that involves the phosphorylation of p38 MAPK, while favouring the
expression and activity of IL-10 and GC alpha-receptors. The synergistic action of IL-10 and
GC can favour recovery in injured intestinal epithelium of UC. This would probably occur by
reducing the inflammation-induced intestinal epithelial cell stress, which helps to restore
homeostasis and to isolate the lamina propria from luminal antigens. Furthermore, the molec-
ular changes that affect the response to the GC can be detected in the intestinal epithelium of
patients with UC. Anyway, the results obtained suggest that the intestinal epithelium is a
potential target on the issue of inadequate response to GC in UC.
Supporting Information
S1 Fig. SOCS3 and IkBα p38 MAPK-independent expression in Caco-2 cell monolayers.
Graphs represent fold change values (2-AACt) of SOCS3 (Panel A) and IkBα (Panel B) expres-
sion, with respect to their basal condition (control or DMSO group). p 0.05 vs TNF_GC_IL-
10_SB203580 group.
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